vs

Side-by-side financial comparison of Mativ Holdings, Inc. (MATV) and Natera, Inc. (NTRA). Click either name above to swap in a different company.

Natera, Inc. is the larger business by last-quarter revenue ($665.5M vs $463.1M, roughly 1.4× Mativ Holdings, Inc.). Mativ Holdings, Inc. runs the higher net margin — 21.8% vs 7.1%, a 14.7% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 1.0%). Natera, Inc. produced more free cash flow last quarter ($37.8M vs $8.0M). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs -3.8%).

Mativ Holdings, Inc. is a global specialty materials manufacturer producing high-performance advanced polymers, nonwovens, filtration solutions, and functional coated materials. It serves healthcare, industrial, consumer goods, aerospace, and energy segments, with operations across North America, Europe, and Asia Pacific.

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

MATV vs NTRA — Head-to-Head

Bigger by revenue
NTRA
NTRA
1.4× larger
NTRA
$665.5M
$463.1M
MATV
Growing faster (revenue YoY)
NTRA
NTRA
+38.8% gap
NTRA
39.8%
1.0%
MATV
Higher net margin
MATV
MATV
14.7% more per $
MATV
21.8%
7.1%
NTRA
More free cash flow
NTRA
NTRA
$29.8M more FCF
NTRA
$37.8M
$8.0M
MATV
Faster 2-yr revenue CAGR
NTRA
NTRA
Annualised
NTRA
34.5%
-3.8%
MATV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MATV
MATV
NTRA
NTRA
Revenue
$463.1M
$665.5M
Net Profit
$100.8M
$47.3M
Gross Margin
18.8%
Operating Margin
2.2%
-3.4%
Net Margin
21.8%
7.1%
Revenue YoY
1.0%
39.8%
Net Profit YoY
6620.0%
187.9%
EPS (diluted)
$1.87
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MATV
MATV
NTRA
NTRA
Q4 25
$463.1M
$665.5M
Q3 25
$513.7M
$592.2M
Q2 25
$525.4M
$546.6M
Q1 25
$484.8M
$501.8M
Q4 24
$458.6M
$476.1M
Q3 24
$498.5M
$439.8M
Q2 24
$523.8M
$413.4M
Q1 24
$500.2M
$367.7M
Net Profit
MATV
MATV
NTRA
NTRA
Q4 25
$100.8M
$47.3M
Q3 25
$-3.2M
$-87.5M
Q2 25
$-9.5M
$-100.9M
Q1 25
$-425.5M
$-66.9M
Q4 24
$1.5M
$-53.8M
Q3 24
$-20.8M
$-31.6M
Q2 24
$-1.4M
$-37.5M
Q1 24
$-28.0M
$-67.6M
Gross Margin
MATV
MATV
NTRA
NTRA
Q4 25
18.8%
Q3 25
19.3%
Q2 25
19.7%
Q1 25
15.0%
Q4 24
16.9%
Q3 24
18.8%
Q2 24
20.8%
Q1 24
16.8%
Operating Margin
MATV
MATV
NTRA
NTRA
Q4 25
2.2%
-3.4%
Q3 25
3.1%
-16.5%
Q2 25
3.8%
-20.2%
Q1 25
-88.8%
-15.8%
Q4 24
0.6%
-13.6%
Q3 24
1.4%
-8.9%
Q2 24
2.0%
-10.6%
Q1 24
-2.8%
-20.2%
Net Margin
MATV
MATV
NTRA
NTRA
Q4 25
21.8%
7.1%
Q3 25
-0.6%
-14.8%
Q2 25
-1.8%
-18.5%
Q1 25
-87.8%
-13.3%
Q4 24
0.3%
-11.3%
Q3 24
-4.2%
-7.2%
Q2 24
-0.3%
-9.1%
Q1 24
-5.6%
-18.4%
EPS (diluted)
MATV
MATV
NTRA
NTRA
Q4 25
$1.87
$0.36
Q3 25
$-0.06
$-0.64
Q2 25
$-0.18
$-0.74
Q1 25
$-7.82
$-0.50
Q4 24
$0.03
$-0.41
Q3 24
$-0.38
$-0.26
Q2 24
$-0.03
$-0.30
Q1 24
$-0.52
$-0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MATV
MATV
NTRA
NTRA
Cash + ST InvestmentsLiquidity on hand
$84.2M
Total DebtLower is stronger
$1.0B
Stockholders' EquityBook value
$498.7M
$1.7B
Total Assets
$2.1B
$2.4B
Debt / EquityLower = less leverage
2.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MATV
MATV
NTRA
NTRA
Q4 25
$84.2M
Q3 25
$97.1M
$1.0M
Q2 25
$95.6M
$16.0M
Q1 25
$84.0M
$17.8M
Q4 24
$94.3M
$22.7M
Q3 24
$162.2M
$29.5M
Q2 24
$133.4M
$90.3M
Q1 24
$128.9M
$69.1M
Total Debt
MATV
MATV
NTRA
NTRA
Q4 25
$1.0B
Q3 25
$1.0B
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$1.1B
Q3 24
$1.2B
Q2 24
$1.2B
Q1 24
$1.2B
Stockholders' Equity
MATV
MATV
NTRA
NTRA
Q4 25
$498.7M
$1.7B
Q3 25
$397.4M
$1.3B
Q2 25
$416.6M
$1.2B
Q1 25
$428.2M
$1.2B
Q4 24
$858.5M
$1.2B
Q3 24
$882.3M
$878.5M
Q2 24
$898.0M
$836.5M
Q1 24
$906.9M
$794.1M
Total Assets
MATV
MATV
NTRA
NTRA
Q4 25
$2.1B
$2.4B
Q3 25
$2.0B
$1.8B
Q2 25
$2.1B
$1.8B
Q1 25
$2.1B
$1.7B
Q4 24
$2.4B
$1.7B
Q3 24
$2.6B
$1.6B
Q2 24
$2.6B
$1.5B
Q1 24
$2.7B
$1.5B
Debt / Equity
MATV
MATV
NTRA
NTRA
Q4 25
2.07×
Q3 25
2.63×
Q2 25
2.66×
Q1 25
2.67×
Q4 24
1.30×
Q3 24
1.32×
Q2 24
1.29×
Q1 24
1.30×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MATV
MATV
NTRA
NTRA
Operating Cash FlowLast quarter
$19.3M
$73.9M
Free Cash FlowOCF − Capex
$8.0M
$37.8M
FCF MarginFCF / Revenue
1.7%
5.7%
Capex IntensityCapex / Revenue
2.4%
5.4%
Cash ConversionOCF / Net Profit
0.19×
1.56×
TTM Free Cash FlowTrailing 4 quarters
$93.8M
$109.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MATV
MATV
NTRA
NTRA
Q4 25
$19.3M
$73.9M
Q3 25
$72.8M
$59.4M
Q2 25
$57.6M
$37.6M
Q1 25
$-15.9M
$44.5M
Q4 24
$24.1M
$52.9M
Q3 24
$37.6M
$51.8M
Q2 24
$46.1M
$4.0M
Q1 24
$-13.0M
$27.0M
Free Cash Flow
MATV
MATV
NTRA
NTRA
Q4 25
$8.0M
$37.8M
Q3 25
$66.7M
$37.0M
Q2 25
$48.9M
$11.7M
Q1 25
$-29.8M
$22.6M
Q4 24
$2.0M
$34.8M
Q3 24
$25.5M
$35.5M
Q2 24
$37.4M
$-7.7M
Q1 24
$-25.1M
$6.7M
FCF Margin
MATV
MATV
NTRA
NTRA
Q4 25
1.7%
5.7%
Q3 25
13.0%
6.2%
Q2 25
9.3%
2.1%
Q1 25
-6.1%
4.5%
Q4 24
0.4%
7.3%
Q3 24
5.1%
8.1%
Q2 24
7.1%
-1.9%
Q1 24
-5.0%
1.8%
Capex Intensity
MATV
MATV
NTRA
NTRA
Q4 25
2.4%
5.4%
Q3 25
1.2%
3.8%
Q2 25
1.7%
4.7%
Q1 25
2.9%
4.3%
Q4 24
4.8%
3.8%
Q3 24
2.4%
3.7%
Q2 24
1.7%
2.8%
Q1 24
2.4%
5.5%
Cash Conversion
MATV
MATV
NTRA
NTRA
Q4 25
0.19×
1.56×
Q3 25
Q2 25
Q1 25
Q4 24
16.07×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MATV
MATV

Other$208.7M45%
SAS Segment$157.4M34%
FAM Segment$97.0M21%

NTRA
NTRA

Segment breakdown not available.

Related Comparisons